Glaxo to Put Older Drugs in New Unit That May Be Sold

GlaxoSmithKline Plc plans to form a new unit to house more than 50 older products such as the Zantac antacid, prompting speculation that the U.K.’s largest drugmaker may sell the brands.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.